Ultragenyx Pharmaceutical (RARE) Return on Capital Employed (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 323.00 |
| Dec 31, 2025 | 515.00 |
| Sep 30, 2025 | -1,017.00 |
| Jun 30, 2025 | -369.00 |
| Mar 31, 2025 | -48.00 |
| Dec 31, 2024 | -415.00 |
| Sep 30, 2024 | 470.00 |
| Jun 30, 2024 | 420.00 |
| Mar 31, 2024 | 218.00 |
| Dec 31, 2023 | 559.00 |
| Sep 30, 2023 | 292.00 |
| Jun 30, 2023 | -752.00 |
| Mar 31, 2023 | -434.00 |
| Dec 31, 2022 | -36.00 |
| Sep 30, 2022 | -719.00 |
| Jun 30, 2022 | -956.00 |
| Mar 31, 2022 | -315.00 |
| Dec 31, 2021 | -133.00 |
| Sep 30, 2021 | -403.00 |
| Jun 30, 2021 | -314.00 |
| Mar 31, 2021 | 456.00 |
| Mar 31, 2020 | 177.00 |
| Dec 31, 2019 | 376.00 |
| Sep 30, 2019 | -754.00 |
| Jun 30, 2019 | 383.00 |
| Mar 31, 2019 | 867.00 |
| Dec 31, 2018 | -306.00 |
| Sep 30, 2018 | -268.00 |
| Jun 30, 2018 | 972.00 |
| Mar 31, 2018 | 2,434.00 |
| Dec 31, 2017 | -866.00 |
| Sep 30, 2017 | -1,325.00 |
| Jun 30, 2017 | -825.00 |
| Mar 31, 2017 | -75.00 |
| Dec 31, 2016 | -90.00 |
| Sep 30, 2016 | -803.00 |
| Jun 30, 2016 | -898.00 |
| Mar 31, 2016 | -841.00 |
| Dec 31, 2015 | -249.00 |
| Sep 30, 2015 | 163.00 |
| Jun 30, 2015 | 0.00 |
| Mar 31, 2015 | 372.00 |
| Dec 31, 2014 | -149.00 |
| Sep 30, 2014 | -208.00 |
| Jun 30, 2014 | 679.00 |